Key result
Atrial fibrillation impacts major adverse cardiovascular events and mortality outcomes in relation to stroke, coronary artery disease, and peripheral vascular disease.
Why the study?
What is the impact of atrial fibrillation on major adverse cardiovascular events and mortality in relation to stroke, coronary artery disease, and peripheral vascular disease?
What is the impact of atrial fibrillation on major adverse cardiovascular events and mortality in relation to stroke, coronary artery disease, and peripheral vascular disease?
This review highlights the significant impact of atrial fibrillation on major adverse cardiovascular events and mortality in patients with concurrent coronary or peripheral vascular disease.
AF heightens MACE and mortality with coexisting stroke, CAD, or PVD; leaves optimal strategies open for prospective trials.
-VASc have been implemented in clinical practice to determine the risk of cardio-embolic stroke, and need for thrombo-prophylaxis in patients with AF. AF is also closely related to the pathophysiology of other cardiovascular and peripheral vascular disease. Many patients with AF have associated atherosclerosis given that many risk factors for atherosclerosis also predispose to AF. Myocardial infarction (MI) is also closely related to AF and its clinical course is affected by new onset AF. This review elucidates the impact of AF on major adverse cardiovascular events and mortality outcomes in relation to stroke, coronary artery disease and peripheral vascular disease.
No takes yet. Share an insight, caveat, or question.
Maan et al. (2012) conducted a review in Atrial Fibrillation. Atrial fibrillation impacts major adverse cardiovascular events and mortality outcomes in relation to stroke, coronary artery disease, and peripheral vascular disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: